Fund comparison · from official SEC filings
FHLC vs IBB: how much do they overlap?
Fidelity MSCI Health Care Index ETF and iShares Biotechnology ETF
Holdings overlap19%of assets, by weight Shared positions141of 338 / 253 holdings FHLC expense ratio0.08%net, per year IBB expense ratio0.44%net, per year Shared holdings
V
VRTXVERTEX PHARMACEUTICALS INC
1.75%
6.77%
G
GILDGILEAD SCIENCES INC
2.63%
6.64%
A
AMGNAMGEN INC
3.02%
6.63%
R
REGNREGENERON PHARMACEUTICALS
1.18%
5.03%
A
ALNYALNYLAM PHARMACEUTICALS INC
0.66%
5.02%
I
IQVIQVIA HOLDINGS INC
0.44%
2.81%
I
INSMINSMED INC
0.47%
2.61%
M
MTDMETTLER-TOLEDO INTERNATIONAL
0.42%
2.20%
N
NTRANATERA INC
0.44%
1.87%
B
BIIBBIOGEN INC
0.45%
1.80%
U
UTHRUNITED THERAPEUTICS CORP
0.38%
1.61%
W
WATWATERS CORP
0.49%
1.56%
I
INCYINCYTE CORP
0.26%
1.43%
I
ILMNILLUMINA INC
0.31%
1.24%
N
NBIXNEUROCRINE BIOSCIENCES INC
0.21%
1.19%
M
MEDPMEDPACE HOLDINGS INC
0.15%
1.02%
E
EXELEXELIXIS INC
0.18%
0.94%
I
IONSIONIS PHARMACEUTICALS INC
0.19%
0.91%
B
BMRNBIOMARIN PHARMACEUTICAL INC
0.16%
0.90%
M
MDGLMADRIGAL PHARMACEUTICALS INC
0.12%
0.81%
M
MRNAMODERNA INC
0.26%
0.78%
T
TECHBIO-TECHNE CORP
0.14%
0.75%
H
HALOHALOZYME THERAPEUTICS INC
0.12%
0.74%
B
BBIOBRIDGEBIO PHARMA INC
0.17%
0.74%
T
TEMTEMPUS AI INC-CL A
0.08%
0.68%
Only in FHLC
L
LLYELI LILLY & CO
12.15%
J
JNJJOHNSON & JOHNSON
8.96%
A
ABBVABBVIE INC
6.04%
U
UNHUNITEDHEALTH GROUP INC
5.43%
M
MRKMERCK & CO. INC.
4.38%
T
TMOTHERMO FISHER SCIENTIFIC INC
2.91%
I
ISRGINTUITIVE SURGICAL INC
2.62%
A
ABTABBOTT LABORATORIES
2.55%
P
PFEPFIZER INC
2.45%
B
BMYBRISTOL-MYERS SQUIBB CO
1.99%
D
DHRDANAHER CORP
1.84%
S
SYKSTRYKER CORP
1.75%
C
CVSCVS HEALTH CORP
1.71%
M
MDTMEDTRONIC PLC
1.68%
M
MCKMCKESSON CORP
1.63%
B
BSXBOSTON SCIENTIFIC CORP
1.38%
E
ELVELEVANCE HEALTH INC
1.35%
C
CITHE CIGNA GROUP
1.26%
H
HCAHCA HEALTHCARE INC
1.12%
C
CORCENCORA INC
0.92%
Z
ZTSZOETIS INC
0.82%
E
EWEDWARDS LIFESCIENCES CORP
0.78%
C
CAHCARDINAL HEALTH INC
0.74%
I
IDXXIDEXX LABORATORIES INC
0.72%
B
BDXBECTON DICKINSON AND CO
0.69%
Only in IBB
B
BISXXBCF INSTITUTIONAL-SL AGNCY
11.65%
A
ARGXARGENX SE - ADR
2.78%
O
ONCBEONE MEDICINES LTD-ADR
1.86%
G
GMABGENMAB A/S -SP ADR
1.22%
A
ASNDASCENDIS PHARMA A/S
0.74%
2
2GHMERUS NV
0.56%
B
BNTXBIONTECH SE-ADR
0.55%
V
VRNAVERONA PHARMA PLC - ADR
0.52%
?
—Avidity Biosciences, Inc.
0.44%
L
LEGNLEGEND BIOTECH CORP-ADR
0.36%
A
ACLXARCELLX INC
0.30%
A
AKROAKERO THERAPEUTICS INC
0.29%
Z
ZLABZAI LAB LTD-ADR
0.23%
A
AM6AMICUS THERAPEUTICS INC
0.21%
S
SMMTSUMMIT THERAPEUTICS INC
0.20%
X
XTSLABLCKRCK CASH-TRSRY-SL AGNCY
0.17%
2
260CENTESSA PHARMACEUTICALS-ADR
0.13%
I
IMCRIMMUNOCORE HOLDINGS PLC-ADR
0.11%
S
STVNSTEVANATO GROUP SPA
0.11%
G
GRFSGRIFOLS SA-ADR
0.11%
L
LKFTLAKEFRONT BIOTHERAPEUTIC-ADR
0.11%
D
DVAXDYNAVAX TECHNOLOGIES CORP
0.10%
A
ABCLABCELLERA BIOLOGICS INC
0.10%
Hold FHLC and IBB together? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →Other comparisons you might like
Data source: official SEC Form N-PORT filings from each fund. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.